Global Cardiovascular System Medicine Sales by Country

In 2023, Croatia topped the list in global cardiovascular medicine sales per capita, followed by South Korea and Portugal. Significant growth in South Korea was observed with a 9.06% increase, whereas Hungary, Austria, and Norway saw slight declines. The United Kingdom experienced a negligible decrease, contrasting with New Zealand's notable 7.66% rise. Costa Rica's sales also grew modestly. Overall, the market shows varying trends, with some countries demonstrating significant sales growth.

Future trends to watch include the impact of aging populations in developed countries, increased healthcare awareness, and advancements in cardiovascular treatments which may further influence sales dynamics globally. Emerging markets may also play a crucial role in the growth trajectory.

Top countries in Cardiovascular System Medicine Sales by Country

# 10 Countries US Dollars PPP Per Capita Last Year YoY 5-years CAGR
1 1 Croatia 525.4 2023 +0.98% +3.58% View data
2 2 South Korea 131.3 2023 +8.07% +9.06% View data
3 3 Portugal 109.7 2023 +5.89% +5.48% View data
4 4 Spain 93.8 2023 +4.45% +3.81% View data
5 5 Germany 80.1 2023 +0.12% +1.46% View data
6 6 Hungary 63.5 2023 -1.24% -1.53% View data
7 7 Austria 55.7 2023 -1.42% -1.96% View data
8 8 Estonia 47.9 2023 0% +2.04% View data
9 9 Sweden 35.6 2023 -0.28% +4.77% View data
10 10 Norway 33.1 2023 -2.36% -0.54% View data

Top Countries about Cardiovascular Drug